|
ZNF131 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.468400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.965000E-01 |
| Normal-vs-Stage2 |
9.287600E-01 |
| Normal-vs-Stage3 |
4.912200E-01 |
| Normal-vs-Stage4 |
5.962600E-01 |
| Stage1-vs-Stage2 |
4.740800E-01 |
| Stage1-vs-Stage3 |
9.460200E-01 |
| Stage1-vs-Stage4 |
9.657200E-01 |
| Stage2-vs-Stage3 |
5.815600E-01 |
| Stage2-vs-Stage4 |
7.192200E-01 |
| Stage3-vs-Stage4 |
9.419600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.925400E-01 |
| Normal-vs-AfricanAmerican |
4.444800E-01 |
| Normal-vs-Asian |
4.542400E-01 |
| Caucasian-vs-AfricanAmerican |
9.348000E-01 |
| Caucasian-vs-Asian |
5.400600E-01 |
| AfricanAmerican-vs-Asian |
6.720000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.716400E-01 |
| Normal-vs-Female |
8.492400E-01 |
| Male-vs-Female |
2.489400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.184800E-01 |
| Normal-vs-Extreme_Weight |
4.181600E-01 |
| Normal-vs-Obese |
3.351200E-01 |
| Normal-vs-Extreme_Obese |
9.015800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.601400E-01 |
| Normal_Weight-vs-Obese |
8.688800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.159600E-01 |
| Extreme_Weight-vs-Obese |
9.018000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.461200E-01 |
| Obese-vs-Extreme_Obese |
4.021200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.633200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.632000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.483820E-01 |
| Normal-vs-Age(81-100Yrs) |
8.959900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.838600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.080600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.417600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.237900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.290300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.638760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.517400E-01 |
| Normal-VS-Type2 PRCC |
6.379300E-03 |
| Normal-VS-KIRP CIMP |
3.568100E-02 |
| Normal-VS-Unclassified PRCC |
8.099800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.458460E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.488400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.516800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.801000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.791700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.971970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.277800E-02 |
| Normal-vs-N1 |
8.232800E-01 |
| Normal-vs-N2 |
1.600970E-03 |
| N0-vs-N1 |
6.507900E-02 |
| N0-vs-N2 |
1.040230E-01 |
| N1-vs-N2 |
4.840100E-02 |
|
|
